Generalized multidimensional dynamic allocation method

Dynamic allocation has received considerable attention since it was first proposed in the 1970s as an alternative means of allocating treatments in clinical trials which helps to secure the balance of prognostic factors across treatment groups. The purpose of this paper is to present a generalized multidimensional dynamic allocation method that simultaneously balances treatment assignments at three key levels: within the overall study, within each level of each prognostic factor, and within each stratum, that is, combination of levels of different factors Further it offers capabilities for unbalanced and adaptive designs for trials. The treatment balancing performance of the proposed method is investigated through simulations which compare multidimensional dynamic allocation with traditional stratified block randomization and the Pocock-Simon method. On the basis of these results, we conclude that this generalized multidimensional dynamic allocation method is an improvement over conventional dynamic allocation methods and is flexible enough to be applied for most trial settings including Phases I, II and III trials.

[1]  Toshiro Tango,et al.  Permutation Test Following Covariate-Adaptive Randomization in Randomized Controlled Trials , 2009, Journal of biopharmaceutical statistics.

[2]  C. Dunnett.  A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .

[3]  G. Kundt.  Comparative evaluation of balancing properties of stratified randomization procedures. , 2009, Methods of information in medicine.

[4]  J C Dumville,et al.  The use of unequal randomisation ratios in clinical trials: a review. , 2006, Contemporary clinical trials.

[5]  Damian McEntegart,et al.  Randomization by minimization for unbalanced treatment allocation , 2009, Statistics in medicine.

[6]  Jun Shao,et al.  A theory for testing hypotheses under covariate-adaptive randomization , 2010 .

[7]  C. Dunnett.  Pairwise Multiple Comparisons in the Unequal Variance Case , 1980 .

[8]  Damian McEntegart,et al.  The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview , 2003 .

[9]  Yasuo Ohashi,et al.  Statistical comparison of random allocation methods in cancer clinical trials. , 2004, Controlled clinical trials.

[10]  D R Taves,et al.  Minimization: A new method of assigning patients to treatment and control groups , 1974, Clinical pharmacology and therapeutics.

[11]  V W Berger,et al.  Pros and cons of permutation tests in clinical trials. , 2000, Statistics in medicine.

[12]  Mark Donovan,et al.  Use of simulation to compare the performance of minimization with stratified blocked randomization , 2009, Pharmaceutical statistics.

[13]  K. Lees,et al.  Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial , 2003, Statistics in medicine.

[14]  S. Pocock,et al.  Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.

[15]  W. Rosenberger,et al.  The theory of response-adaptive randomization in clinical trials , 2006 .

[16]  Gregory R Pond,et al.  Trends in the application of dynamic allocation methods in multi-arm cancer clinical trials , 2010, Clinical trials.

[17]  G. Pond,et al.  Statistical issues in the use of dynamic allocation methods for balancing baseline covariates , 2011, British Journal of Cancer.

[18]  Patrick Royston,et al.  The design of simulation studies in medical statistics , 2006, Statistics in medicine.

[19]  A Hallstrom,et al.  Imbalance in treatment assignments in stratified blocked randomization. , 1988, Controlled clinical trials.

[20]  William F. Rosenberger,et al.  Implementing Optimal Allocation in Sequential Binary Response Experiments , 2007 .

[21]  Julia Brown,et al.  Minimization—reducing predictability for multi‐centre trials whilst retaining balance within centre , 2005, Statistics in medicine.

[22]  D. Taves,et al.  The use of minimization in clinical trials. , 2010, Contemporary clinical trials.